Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer.

Chengpei ZhuJingnan XueYunchao WangShanshan WangNan ZhangYanyu WangLonghao ZhangXu YangJunyu LongXiaobo YangXinting SangHaitao Zhao

Published in: Frontiers in immunology (2023)

Lenvatinib combined with PD-1/PD-L1 inhibitors and Gemox chemotherapy represents an effective and tolerable treatment option in patients with advanced BTC.

Keyphrases

locally advanced
papillary thyroid
squamous cell
squamous cell carcinoma
rectal cancer
radiation therapy
young adults